KKR & Co. Inc. (KKR) Stock Price & Analysis
KKR & Co. Inc. (KKR) closed at USD 93.09 on Thursday, October 22, 2026, up 3.58% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 93.09; the Oct 22, 2026 session ranged USD 88.63–93.16 on volume of 5,538,713 shares. Market capitalization is —, with a 52-week range of USD 82.67–144.84 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/KKR.md
Key facts (KKR)
- Last four reported quarters (through Jun 30, 2026): revenue $21.3B, net income $3.15B (14.8% margin) (SEC filings).
- Valuation: P/E 27.3x.
- 7 of 80 tracked superinvestors hold KKR (13F, Q2 2026): 2 new, 1 added, 3 reduced, 1 unchanged.
- Total return with dividends: 1Y -22.5% vs S&P 500 +14.9%; 5Y +32.0% vs S&P 500 +80.3%.
- Next earnings: 2026-11-09, EPS estimate USD 1.58, revenue estimate $2.61B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (KKR)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $16.2B | $5.70B | $14.5B | $21.9B | $19.5B | $21.3B |
| Net income | $4.73B | -$522M | $3.73B | $3.08B | $2.37B | $3.15B |
| Net margin | 29.2% | -9.1% | 25.7% | 14.1% | 12.2% | 14.8% |
| Revenue growth | +283.5% | -64.8% | +154.2% | +50.9% | -11.0% | — |
| Cash + short-term investments | $10.5B | $13.4B | $20.8B | $15.4B | $17.2B | — |
| Total debt | $36.9B | — | — | — | — | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (KKR)
P/E 27.3x · P/S 4.0x · P/B 2.8x · Earnings yield 3.67% · Dividend yield (paid, TTM) 0.78% · Buyback yield (TTM) 0.27%
Superinvestors (SEC 13F-HR, Q2 2026) (KKR)
7 of 80 tracked investors hold KKR. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Chuck Akre | Akre Capital Management | 8.95% | $457M | Reduced -25.9% |
| ValueAct Capital | 5.80% | $327M | Added +8.5% | |
| Lindsell Train | 2.33% | $61.3M | New position | |
| Thomas Gayner | Markel Group | 1.01% | $133M | Unchanged |
| Dodge & Cox Funds | Dodge & Cox | 0.39% | $740M | New position |
| John Rogers | Ariel Investments | 0.39% | $38.9M | Reduced -3.5% |
| Bill Nygren | Oakmark Funds | 0.04% | $31.6M | Reduced -7.0% |
Analysts (KKR)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Piper Sandler | Target lowered | Overweight | $128 → $121 |
| 2026-10-13 | UBS | Target lowered | Buy | $123 → $122 |
| 2026-10-12 | TD Cowen | Target lowered | Hold | $118 → $103 |
| 2026-10-08 | Barclays | Target lowered | Overweight | $135 → $130 |
| 2026-10-02 | Wells Fargo | Initiated | Equal-Weight | $97 |
| 2026-08-27 | Oppenheimer | Target raised | Outperform | $139 → $166 |
| 2026-08-04 | Argus Research | Target raised | Buy | $115 → $125 |
| 2026-08-03 | TD Cowen | Target raised | Hold | $108 → $111 |
| 2026-08-03 | BMO Capital | Target raised | Outperform | $112 → $118 |
| 2026-07-31 | RBC Capital | Target raised | Outperform | $125 → $134 |
| 2026-07-31 | Barclays | Target raised | Overweight | $124 → $135 |
| 2026-07-21 | Morgan Stanley | Target lowered | Overweight | $153 → $147 |
Total return (dividends reinvested) (KKR)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -22.5% | +32.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -22.6% | +5.7% |
| Volatility (annualized) | 38.0% | 38.3% |
| Max drawdown | -41.1% (Dec 2025→Mar 2026) | -48.2% (Jan 2025→Mar 2026) |
KKR analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.58 | $1.59 | -0.4% | $2.61B | 17 |
| Next quarter (ends Dec 2026) | $3.51 | $1.70 | +106.6% | $4.11B | 15 |
| Current fiscal year (ends Dec 2026) | $7.92 | $6.12 | +29.5% | $11.93B | 22 |
| Next fiscal year (ends Dec 2027) | $7.22 | $7.35 | -1.7% | $12.37B | 22 |
KKR options: expected move
Options price a move of about ±8.5% (±$7.95) by Nov 13, 2026, which includes earnings on Nov 9, 2026; the earnings reaction alone is priced at about ±1.3%.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 42.2% | ±5.0% |
| Nov 6, 2026 | 14 | 44.3% | ±7.2% |
| Nov 13, 2026 | 21 | 43.5% | ±8.5% |
| Nov 20, 2026 | 28 | 43.9% | ±9.9% |
| Nov 27, 2026 | 35 | 41.3% | ±10.3% |
| Dec 4, 2026 | 42 | 43.5% | ±11.9% |
| Dec 18, 2026 | 56 | 40.5% | ±12.8% |
| Jan 15, 2027 | 84 | 40.0% | ±15.4% |
30-day implied volatility 42.7% vs 31% realized over the last 30 trading days. Put/call ratio (volume) 1.01. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 93.09 |
|---|---|
| Change | ▲ 3.58% (up) |
| Previous Close | USD 93.09 |
| Open | USD 93.09 |
| Day Range | USD 88.63 – 93.16 |
| 52-Week Range | USD 82.67 – 144.84 |
| Volume | 5,538,713 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (KKR)
Nexqual's technical model rates KKR "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.33 (neutral) |
| vs SMA50 | Below (USD 99.14) |
| MACD | -2.51 (negative) |
Earnings (KKR)
| Next Earnings Date | 2026-11-09 |
|---|---|
| EPS Estimate | USD 1.58 |
| Revenue Estimate | $2.61B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.63 vs est 1.43 ▲ beat |
| 2026-03-31 | USD 1.39 vs est 1.26 ▲ beat |
| 2025-12-31 | USD 1.12 vs est 1.14 ▼ miss |
| 2025-09-30 | USD 1.41 vs est 1.3 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (KKR)
| Total Revenue | $25.83B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +7.80% |
| Gross Margin | +54.77% |
| Operating Margin | +20.65% |
| Profit Margin | +12.20% |
| ROE | +7.28% |
| Debt / Equity | 0.7 |
| Current Ratio | 0.86 |
| Total Cash | $47.56B |
| Total Debt | $56.16B |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (KKR)
Nexqual rates KKR & Co. Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 55%, operating 21% (last 12 months) |
| Balance Sheet | Mixed — $47.6B cash vs $56.2B debt |
| Cash Flow | Solid — Operating cash flow $478M (FY ended Dec 2025, 10-K) |
| Efficiency | Mixed — ROE 7%, ROA 1.4% |
Ownership (KKR)
| Insider Ownership | +23.05% |
|---|---|
| Institutional Ownership | +62.29% |
| Shares Outstanding | 897.64M |
| Float | 690.58M |
| Short % of Float | +2.00% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BN | Brookfield Corporation | USD 38.28 | ▲ 2.05% |
| BAM | Brookfield Asset Management Inc | USD 47.64 | ▲ 3.45% |
| APO | Apollo Global Management, Inc. | USD 114.83 | ▲ 2.81% |
| BX | Blackstone Inc. | USD 118.75 | ▲ 8.38% |
| STT | State Street Corporation | USD 167.84 | ▼ 0.66% |
| AMP | Ameriprise Financial, Inc. | USD 496.83 | ▲ 1.29% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt